Variation in IGF2BP2 interacts with adiposity to alter insulin sensitivity in Mexican Americans

Obesity

Volumn 17, Issue 4, 2009, Pages 729-736

  Li, Xia ^a   Allayee, Hooman ^a   Xiang, Anny H ^a   Trigo, Enrique ^a   Hartiala, Jaana ^a   Lawrence, Jean M ^b   Buchanan, Thomas A ^a   Watanabe, Richard M ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Kaiser Permanente Southern California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMP 2 PROTEIN, HUMAN; IMP-2 PROTEIN, HUMAN; RNA BINDING PROTEIN;

ADIPOSE TISSUE; ADULT; ARTICLE; ETHNOLOGY; FEMALE; GENETIC PREDISPOSITION; GENETICS; GLUCOSE TOLERANCE TEST; HISPANIC; HUMAN; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHOTON ABSORPTIOMETRY; PREGNANCY; PREGNANCY DIABETES MELLITUS; SINGLE NUCLEOTIDE POLYMORPHISM;

ABSORPTIOMETRY, PHOTON; ADIPOSE TISSUE; ADIPOSITY; ADULT; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; MALE; MEXICAN AMERICANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; RNA-BINDING PROTEINS;

EID: 63049114182     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.593     Document Type: Article

References (38)

1. Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research, Saxena R, Voight BF et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007;316: 1331-1336.
2. Scott LJ, Mohlke KL, Bonnycastle LL et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007;316:1341-1345.
3. Zeggini E, Weedon MN, Lindgren CM et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007;316:1336-1341.
4. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995;16:3-34.
5. Nielsen J, Christiansen J, Lykke-Andersen J et al. A family of insulinlike growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol 1999;19:1262-1270.
6. Kjos SL, Peters RK, Xiang A et al. Predicting future diabetes in Latino women with gestational diabetes. Diabetes 1995;44:586-591.
7. Peters RK, Kjos SL, Xiang A, Buchanan TA. Long-term diabetogenic effect of single pregnancy in women with previous gestational diabetes mellitus. Lancet 1996;347:227-230.
8. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes. Diabetes Care 2002;25:1862-1868.
9. Buchanan TA, Metzger BE, Freinkel N, Bergman RN. Insulin sensitivity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. Am J Obstet Gynecol 1990;162: 1008-1014.
10. Buchanan TA, Xiang A, Kjos SL et al. Gestational diabetes: antepartum characteristics that predict postpartum glucose intolerance and type 2 diabetes in Latino women. Diabetes 1998;47:1302-1310.
11. Buchanan TA, Xiang AH, Kjos SL et al. Antepartum predictors of the development of type 2 diabetes in Latino women 11-26 months after pregnancies complicated by gestational diabetes. Diabetes 1999;48:2430-2436.
12. Buchanan TA, Xiang AH, Peters RK et al. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 2002;51:2796-2803.
13. Xiang AH, Peters RK, Kjos SL et al. Effect of pioglitazone on pancreatic b-cell function and diabetes risk in Hispanic women with prior gestational diabetes. Diabetes 2006;55:517-522.
14. DeFronzo RA. The triumvirate: b-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1987;37:667-687.
15. Bergman RN. Toward physiological understanding of glucose tolerance. Minimal model approach. Diabetes 1989;38:1512-1527.
16. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
17. Watanabe RM, Xiang A, Trigo E et al. Evidence of genetic predisposition for B-cell dysfunction in Mexican-American families of probands with gestational diabetes. Diabetes 2003;52(Suppl 1):A257.
18. Bergman RN, Zaccaro DJ, Watanabe RM et al. Minimal model-based insulin sensitivity has greater heritability and a different genetic basis than homeostasis model assessment or fasting insulin. Diabetes 2003;52:2168-2174.
19. Prokunina-Olsson L, Hanisch JJ, Jackson AU et al. A novel variant of IGF2BP2 is associated with type 2 diabetes and affects expression of a functional splicing isoform. Diabetes 2008;57(Suppl 1):A61.
20. Livak KJ. Allelic discrimination using fluorogenic probes and the 5? nuclease assay. Genet Anal 1999;14:143-149.
21. Livak KJ. SNP genotyping by the 5′-nuclease reaction. Methods Mol Biol 2003;212:129-147.
22. Bergman RN, Ider YZ, Bowden CR, Cobelli C. Quantitative estimation of insulin sensitivity. Am J Physiol 1979;236:E667-E677.
23. Boston RC, Stefanovski D, Moate PJ et al. MINMOD Millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test. Diabetes Technol Ther 2003;5:1003-1015.
24. Bergman RN, Phillips LS, Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 1981;68:1456-1467.
25. O'Connell JR, Weeks DE. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 1998;63:259-266.
26. Wigginton JE, Abecasis GR. PEDSTATS: descriptive statistics, graphics and quality assessment for gene mapping data. Bioinformatics 2005;21:3445-3447.
27. Blangero J, Almasy L. Multipoint oligogenic linkage analysis of quantitative traits. Genet Epidemiol 1997;14:959-964.
28. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 1998;62:1198-1211.
29. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-265.
30. Gabriel SB, Schaffner SF, Nguyen H et al. The structure of haplotype blocks in the human genome. Science 2002;296:2225-2229.
31. Conneely KN, Boehnke M. So many correlated tests, so little time! Rapid adjustment of P values for multiple correlated tests. Am J Hum Genet 2007;81:1158-1168.
32. Pascoe L, Tura A, Patel SK et al. Common variants of the novel type 2 diabetes genes CDKAL1 and HHEX/IDE are associated with decreased pancreatic beta-cell function. Diabetes 2007;56:3101-3104.
33. Grarup N, Rose CS, Andersson EA et al. Studies of association of variants near the HHEX, CDKN2A/B, and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10,705 Danish subjects: validation and extension of genome-wide association studies. Diabetes 2007;56:3105-3111.
34. Horikoshi M, Hara K, Ito C et al. Variations in the HHEX gene are associated with increased risk of type 2 diabetes in the Japanese population. Diabetologia 2007;50:2461-2466.
35. Omori S, Tanaka Y, Takahashi A et al. Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population. Diabetes 2008;57: 791-795.
36. Palmer ND, Goodarzi MO, Langefeld CD et al. Quantitative trait analysis of type 2 diabetes susceptibility loci identified from whole genome association studies in the Insulin Resistance Atherosclerosis Family study. Diabetes 2008;57:1093-1100.
37. Rabinowitz D, Laird N. A unified approach to adjusting association tests for population admixture with arbitrary pedigree structure and arbitrary missing marker information. Hum Hered 2000;50:211-223.
38. Laird NM, Horvath S, Xu X. Implementing a unified approach to family-based tests of association. Genet Epidemiol 2000;19(Suppl 1):36-42.